ELI LILLY & Co — Director's Dealing 2022

Jun 3, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2022-06-01

Reporting Person: Rau Diogo (SVP & CIDO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-01	Common Stock	M	7560	—	Acquired	7560	Direct
2022-06-01	Common Stock	F	3166	$313.44	Disposed	4394	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-01	Restricted Stock Unit	$	M	7560	Disposed		Common Stock (7560.0)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

F2: The restricted stock units vest in three installments, 7,560 on June 1, 2022, 6,300 on June 1, 2023, and 6,300 on June 1, 2024.